Peer Review History
| Original SubmissionAugust 13, 2023 |
|---|
|
PONE-D-23-25885Mechanisms of active diffusion of vesicular stomatitis virus inclusion bodies and cellular early endosomes in the cytoplasm of mammalian cellsPLOS ONE Dear Dr. Lyles, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Dear Dr. Lyles, Thank you for your patience while your manuscript "Mechanisms of active diffusion of vesicular stomatitis virus inclusion bodies and cellular early endosomes in the cytoplasm of mammalian cells" was under peer review at PLoS One. It has now been seen by our referees, whose expertise and comments you will find at the end of this email. From their reports, you will see that they find your work of interest. Nevertheless, they have some minor comments you need to address before we can accept your article for publication. As you can see from their comments, reviewer 1 has some concerns about the significance of the observed movement for trapped inclusion bodies and the effect other phenomena could have on the results, and reviewer 2 has some comments about the statistics and methodology employed. Again, thank you very much for your patience, ============================== Please submit your revised manuscript by Mar 02 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Gilberto Jose Betancor Quintana, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In a previous article, Moran et al. showed that active diffusion of vesicular stomatitis virus (VSV) ribonucleoproteins (RNPs) in the cytoplasm consists of hopping between traps and that actin filaments and myosin II motors are components of this hop-trap mechanism. In this new manuscript, they analyze the random motion of larger structures such as VSV inclusion bodies (that are the major sites of viral RNA synthesis and are formed by liquid-liquid phase separation) and cellular early endosomes. They show that like VSV RNPs, inclusion bodies and early endosomes moved from one trapped state to another, but their size preclude hopping between traps and the apparent state-to-state movement is mediated by essentially driven by trap movement. Finally, they show that latruculin A-induced actin depolymerization increases VSV inclusion body mobility most probaly by increasing the size of the traps. In contrast, depolymerization of actin or microtubules does not affect the size of traps that confine early endosome mobility, suggestingthat intermediate filaments are the major trap components for these organelles. Athough the result is rather expected, the work is well done and the approaches used to analyze the data can be useful to cell biologists in general. Their conclusion that mechanisms of active diffusion can be viewed as a continuum dependent on the size and properties of the particle, with varying proportions of hopping from trap to trap versus motion dependent on trap dynamics is also of general interest. However, I have two comments that I would like the authors to adress. 1) As mentioned by the authors, the movement of trapped inclusion bodies and trapped early endosomes are very small compared to their size, on the order of 100nm (i.e. ~5% of the size of an inclusion body and ~20% of the size of an endosome). On the one hand, this is below optical resolution; on the other, it is in the pixel size range. This raises some questions about the significance of the observation (although I agree that there is a significant difference after latrunculin A treatment at least in the case of inclusion bodies). 2) Finally, can the authors completely exclude that other phenomena are at work? For example, in the case of the rabies virus, the inclusion bodies are of smaller average size after treatment with cytochalasin D which induces their fragmentation. Also, if the composition of the inclusion bodies is affected due to drug treatment, this may affect their properties (viscosity, surface tension and consequently the dynamics of their surface). Reviewer #2: Moran et al., "Mechanisms of active diffusion of vesicular stomatitis virus inclusion bodies and cellular early endosomes in the cytoplasm of mammalian cells," infer the mechanism of movement for VSV inclusion bodies and early endosomes, finding differences in how the particulates move between traps and depend on the cytoskeleton. There is broad interest in understanding how such large compartments move as they cannot rely on passive diffusion. This is particularly important for cells where materials must be transported over long distances (e.g., neurons). I enjoyed the background on the flux of molecules and particulates in the introduction, which was unusually clear, and I commend the authors. I have some suggestions for them on their description of Liquid-liquid phase separation, which I find historically and experimentally inaccurate, but these are mostly minor or simply removable. The authors describe how they image their tracts for MSDs and Beysian analysis particularly well compared to the standard in the field, and the Bayesian analysis provides additional insights that this reviewer finds valuable. Furthermore, the number of tracts and images is relatively high, which makes me confident broadly in the author's work despite these measurements being difficult. I find the work compelling, only have minor comments/suggestions, and feel the manuscript warrants publication. Comments: 1) Can the authors comment on the size distribution statistics and how many VSV inclusion bodies they analyze in Figure 1? A histogram (probably given N~100), violin plot, or a box plot showing all the points and the mean/standard deviation would be appropriate here to properly understand the authors' confidence. The authors should validate whether the particles they track are similar in size. The authors note that size contributes significantly to how particles move within the cytoplasm. Thus, it should be either validated to be similar or possible confounding variables should be discussed. 2) The requirements for LLPS given in lines 106-107 are misleading and incorrect for near diffraction limited objects such as VSV inclusion bodies challenging to validate for LLPS. For example, concerning the claims, (1) two dots coming together could be diffusion within the diffraction limit of particles many nanometers away from each other, and (2) surface curvature is nearly impossible to quantify for most condensates by any technique (as single molecule methods require many particles and lack the detail to see a surface and others such as SIM require deconvolution that is ill-poised for cellular systems that have many aberration and non-gaussian noise considerations that are often overlooked, perhaps the only method suited is STED but few have access to these techniques with the proper fluorophores.) Concerning (iii), most argue that lessened internal motion is a hallmark of LLPS. The best assay to validate phase separation is the saturation assay, albeit even that has considerable caveats. Broadly, the authors, who don't require LLPS for the impact of their paper, should lessen or remove these claims of rules and instead cite the previous papers and move on. 3) Similarly, but more minor. Most in the field prefer to avoid the prefix "liquid-liquid" as it can be misleading to many outside of the polymer field, where the term liquid tends to assume rapid dynamics where polymer liquids can be rather viscoelastic liquids ("glassy"). For example, the most well-accepted phase separation-driven condensate, the nucleolus, has recently been found to have complex viscoelastic properties (Riback et al. et al., Mol Cel 2023). Thus, the language should be corrected in line 102 and in that paragraph. While it is fair and consistent with Flory's use of the term liquid-liquid as a prefix to phase separation to describe polymeric viscoelastic solutions as being driven through those properties, it probably isn't advisable given the contentious nature of LLPS (Musacchio EMBO 2022). 4) Line 115, "like our previous study," is missing a citation. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Mechanisms of active diffusion of vesicular stomatitis virus inclusion bodies and cellular early endosomes in the cytoplasm of mammalian cells PONE-D-23-25885R1 Dear Dr. Lyles, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Gilberto Jose Betancor Quintana, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Dear Prof Lyles, Thank you very much for the revised version of your manuscript, I am glad to announce that your revised manuscript fulfil all the reviewers comments and therefore will be accepted for publication at PLoS One, Once again, I would like to thank you for your patience during the revision process, Best regards, Gilberto Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-25885R1 PLOS ONE Dear Dr. Lyles, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Gilberto Jose Betancor Quintana Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .